Your browser doesn't support javascript.
loading
Increased CXCL8 (IL-8) expression in Multiple Sclerosis.
Lund, Brett T; Ashikian, Nazely; Ta, Huy Q; Chakryan, Yervand; Manoukian, Krikor; Groshen, Susan; Gilmore, Wendy; Cheema, Gurtej S; Stohl, William; Burnett, Margaret E; Ko, David; Kachuck, Norman J; Weiner, Leslie P.
Afiliação
  • Lund BT; Department of Neurology, Keck School of Medicine, University of Southern California, MCH-142, Los Angeles, California 90033, USA. blund@usc.edu
J Neuroimmunol ; 155(1-2): 161-71, 2004 Oct.
Article em En | MEDLINE | ID: mdl-15342208
ABSTRACT
Multiple Sclerosis (MS) is a chronic inflammatory disease of the CNS which is characterized by large mononuclear cell infiltration and significant demyelination. CXCL8 is a chemo-attractant for both neutrophils and monocytes and triggers their firm adhesion to endothelium. In this study, we demonstrate that serum CXCL8 and CXCL8 secretion from PBMCs are significantly higher in untreated MS patients compared to controls and are significantly reduced in MS patients receiving interferon-beta1a therapy. We suggest that CXCL8 may serve as a marker of monocyte activity in MS and may play a role in monocyte recruitment to the CNS.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monócitos / Quimiotaxia de Leucócito / Quimiocinas CXC / Peptídeos e Proteínas de Sinalização Intercelular / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Ano de publicação: 2004 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monócitos / Quimiotaxia de Leucócito / Quimiocinas CXC / Peptídeos e Proteínas de Sinalização Intercelular / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Ano de publicação: 2004 Tipo de documento: Article País de afiliação: Estados Unidos